These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 34018694)
1. Successful treatment of recurrent exit site and tunnel infections caused by atopic dermatitis with dupilumab: A case report. Noda R; Ishibashi Y Ther Apher Dial; 2022 Feb; 26(1):255-256. PubMed ID: 34018694 [No Abstract] [Full Text] [Related]
2. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature. Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073 [TBL] [Abstract][Full Text] [Related]
3. Doolan BJ; Yeon J; Baker DA; Whitfeld MJ AIDS Res Hum Retroviruses; 2022 Feb; 38(2):76-79. PubMed ID: 34384267 [No Abstract] [Full Text] [Related]
4. Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab. Ferrucci S; Tavecchio S; Berti E; Angileri L Clin Exp Dermatol; 2020 Jul; 45(5):625-626. PubMed ID: 32112580 [No Abstract] [Full Text] [Related]
5. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Hansel K; Patruno C; Antonelli E; Dal Bello G; Napolitano M; Fabbrocini G; Grieco T; Pellacani G; Fargnoli MC; Esposito M; Piras V; Zucca M; Girolomoni G; Stingeni L Clin Exp Dermatol; 2022 Jan; 47(1):165-167. PubMed ID: 34309892 [No Abstract] [Full Text] [Related]
6. Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia. Fujishima C; Munemoto S; Hioki C; Sasaki H; Yoshida H; Yamamoto T; Kudo H Eur J Dermatol; 2022 May; 32(3):416-417. PubMed ID: 36065552 [No Abstract] [Full Text] [Related]
7. Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients. Ludriksone L; Elsner P; Schliemann S J Dtsch Dermatol Ges; 2019 Dec; 17(12):1278-1280. PubMed ID: 31829527 [No Abstract] [Full Text] [Related]
8. Successful Use of Dupilumab for Recalcitrant Atopic Dermatitis in an HIV Patient. Marks DH; Piantadosi AL; Patil SU; Raff A; Yu J Dermatitis; 2019; 30(4):276-277. PubMed ID: 31261222 [No Abstract] [Full Text] [Related]
9. Safety and Efficacy of Dupilumab in an Atopic Adolescent With Primary Immune Deficiency. Tanner JF; Knutsen AP; Siegfried E Dermatitis; 2021 Oct; 32(1S):e91-e92. PubMed ID: 34677168 [No Abstract] [Full Text] [Related]
14. Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis. Hanami Y; Yamamoto T J Dermatol; 2024 Sep; 51(9):e291-e292. PubMed ID: 38587252 [No Abstract] [Full Text] [Related]
15. Improved sleep in adults with atopic dermatitis using the treatment dupilumab. Br J Dermatol; 2023 Nov; 189(6):e106. PubMed ID: 37972138 [No Abstract] [Full Text] [Related]
16. [Psoriasis in dupilumab-treated atopic dermatitis]. Senner S; Eicher L; Aszodi N; Prinz JC; French LE; Wollenberg A Hautarzt; 2020 May; 71(5):383-386. PubMed ID: 32179945 [TBL] [Abstract][Full Text] [Related]
17. Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience. Simonetti O; Radi G; Diotallevi F; Molinelli E; Rizzetto G; Offidani A Clin Exp Dermatol; 2021 Jul; 46(5):939-940. PubMed ID: 33576497 [No Abstract] [Full Text] [Related]
18. Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy. Dobkin H; Mullen R; Zirwas M Skinmed; 2019; 17(2):139-140. PubMed ID: 31145072 [No Abstract] [Full Text] [Related]
19. Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab. Cho MK; Shin JU; Kim DH; Lee HJ Clin Exp Dermatol; 2022 Dec; 47(12):2303-2305. PubMed ID: 36006169 [TBL] [Abstract][Full Text] [Related]
20. Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD. Ying Y; Shuang C; Zhen-Ying Z Immun Inflamm Dis; 2022 Mar; 10(3):e574. PubMed ID: 34953055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]